What Trump's reclassification of pot and CBD could mean for seniors, research and stocks - CNBC
Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.
Search Group
Share To
Comments
About Screade
Screade® Inc. version d90e36f, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments